DK3010539T3 - Fremgangsmåder til behandling af nasal polyposis ved administration af en il-4r-antagonist - Google Patents
Fremgangsmåder til behandling af nasal polyposis ved administration af en il-4r-antagonistInfo
- Publication number
- DK3010539T3 DK3010539T3 DK14742021.0T DK14742021T DK3010539T3 DK 3010539 T3 DK3010539 T3 DK 3010539T3 DK 14742021 T DK14742021 T DK 14742021T DK 3010539 T3 DK3010539 T3 DK 3010539T3
- Authority
- DK
- Denmark
- Prior art keywords
- administrating
- antagonist
- methods
- nasal polyposis
- treating nasal
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361837912P | 2013-06-21 | 2013-06-21 | |
| EP14305670 | 2014-05-07 | ||
| PCT/US2014/043440 WO2014205365A1 (en) | 2013-06-21 | 2014-06-20 | Methods for treating nasal polyposis by administering an il-4r antagonist |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3010539T3 true DK3010539T3 (da) | 2019-10-21 |
Family
ID=66440559
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK14742021.0T DK3010539T3 (da) | 2013-06-21 | 2014-06-20 | Fremgangsmåder til behandling af nasal polyposis ved administration af en il-4r-antagonist |
Country Status (10)
| Country | Link |
|---|---|
| JP (3) | JP6640977B2 (hr) |
| DK (1) | DK3010539T3 (hr) |
| ES (1) | ES2747630T3 (hr) |
| HR (1) | HRP20191709T1 (hr) |
| HU (1) | HUE046410T2 (hr) |
| LT (1) | LT3010539T (hr) |
| NZ (1) | NZ631118A (hr) |
| PT (1) | PT3010539T (hr) |
| SG (1) | SG10201912898XA (hr) |
| TW (1) | TWI707694B (hr) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7608693B2 (en) * | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| WO2010120524A2 (en) * | 2009-03-31 | 2010-10-21 | Altair Therapeutics, Inc. | Methods of modulating an immune response to a viral infection |
| UA111731C2 (uk) * | 2010-10-06 | 2016-06-10 | Рідженерон Фармасьютікалз, Інк. | Стабілізована композиція, яка містить антитіло до рецептора інтерлейкіну-4 (іl-4r), варіанти |
| TWI709411B (zh) * | 2013-06-21 | 2020-11-11 | 法商賽諾菲生物技術公司 | Il-4r拮抗劑用於製備治療鼻息肉症的醫藥品之用途 |
-
2014
- 2014-06-20 HU HUE14742021A patent/HUE046410T2/hu unknown
- 2014-06-20 NZ NZ631118A patent/NZ631118A/en unknown
- 2014-06-20 TW TW108101935A patent/TWI707694B/zh active
- 2014-06-20 DK DK14742021.0T patent/DK3010539T3/da active
- 2014-06-20 LT LTEP14742021.0T patent/LT3010539T/lt unknown
- 2014-06-20 SG SG10201912898XA patent/SG10201912898XA/en unknown
- 2014-06-20 PT PT147420210T patent/PT3010539T/pt unknown
- 2014-06-20 ES ES14742021T patent/ES2747630T3/es active Active
-
2018
- 2018-12-27 JP JP2018243929A patent/JP6640977B2/ja active Active
-
2019
- 2019-09-19 HR HRP20191709 patent/HRP20191709T1/hr unknown
- 2019-12-25 JP JP2019233649A patent/JP6898421B2/ja active Active
-
2021
- 2021-06-09 JP JP2021096260A patent/JP2021138743A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG10201912898XA (en) | 2020-02-27 |
| JP2019069987A (ja) | 2019-05-09 |
| PT3010539T (pt) | 2019-10-14 |
| LT3010539T (lt) | 2019-10-10 |
| JP2021138743A (ja) | 2021-09-16 |
| TWI707694B (zh) | 2020-10-21 |
| TW201940193A (zh) | 2019-10-16 |
| JP6640977B2 (ja) | 2020-02-05 |
| JP2020073525A (ja) | 2020-05-14 |
| ES2747630T3 (es) | 2020-03-11 |
| HRP20191709T1 (hr) | 2019-12-13 |
| NZ631118A (en) | 2019-05-31 |
| HUE046410T2 (hu) | 2020-03-30 |
| JP6898421B2 (ja) | 2021-07-07 |
| NZ752224A (en) | 2020-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1222567A1 (zh) | 通過施用 拮抗劑治療鼻息肉症的方法 | |
| DK3004166T3 (da) | Fremgangsmåder til forbedring af allergen-specifik immunterapi ved administration af en il-4r-hæmmer | |
| DK3139986T3 (da) | System til administration af terapeutisk gas | |
| DK2958900T3 (da) | 2-aminopyrimidinderivater til behandling af virusinfektioner | |
| DK2968071T3 (da) | Enhed til oral levering af terapeutiske forbindelser | |
| DK3302565T3 (da) | Faste doseringsformer af palbociclib | |
| DK3019191T3 (da) | Fremgangsmåder til behandling af eosinofil esophagitis ved administration af en IL-4R-hæmmer | |
| DK3023100T3 (da) | Antitumorlægemiddel til intermitterende administration af fgfr-hæmmer | |
| DK2970493T3 (da) | Fremgangsmåder til opnåelse af terapeutisk effektive doser af anti-cd47-midler | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3080100T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
| DK3003309T3 (da) | Behandling af cancer med PI3-kinase-isoform modulatorer | |
| DK2964315T3 (da) | System til behandling af neuromotorisk dysfunktion | |
| DK3003075T3 (da) | Kit til inhalering af fordampede substanser | |
| BR112016009485A2 (pt) | Inalador de medicamento | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| DK2968221T3 (da) | Farmaceutisk sammensætning af s-ketaminhydrochlorid | |
| DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
| DK2948148T3 (da) | Metoder til behandling af autoimmune, åndedræts- og betændelsesforstyrrelser ved inhalation af roflumilast n-oxid | |
| DK3421468T3 (da) | Fremgangsmåder til fremstilling af inhibitorer af re-plikation af influenzavira | |
| DK3049117T3 (da) | Ultralydsmedieret afgivelse af lægemidler | |
| DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom | |
| DK2948134T3 (da) | Sammensætninger til transdermal indgivelse af mtor-inhibitorer | |
| DK2777689T3 (da) | Ny farmaceutisk sammensætning til behandling af svampeinfektioner | |
| DK3632373T3 (da) | Inhalator |